Intratympanic drug delivery for the treatment of inner ear diseases;Vía intratimpánica en el tratamiento de patología de oído interno

Acta Otorrinolaringologica Espanola

Volumn 61, Issue 3, 2010, Pages 225-232

  Herraiz, Carlos ^a,b   Miguel Aparicio, José ^a,b   Plaza, Guillermo ^c  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

Acoustic trauma; Intratympanicdelivery; M ni re's disease; Sensorineural hearing loss; Sudden deafness; Tinnitus

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; EMLA; GENTAMICIN; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO;

DISEASE CONTROL; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG TREATMENT FAILURE; HUMAN; INNER EAR DISEASE; MENIERE DISEASE; SHORT SURVEY; SUDDEN DEAFNESS; VERTIGO;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; GENTAMICINS; HUMANS; LABYRINTH DISEASES; TYMPANIC MEMBRANE;

EID: 77951631003     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otorri.2009.03.008     Document Type: Short Survey

References (53)

1. Plaza G., Herraiz C., and De los Santos G. Myringotomy under topical anesthesia with phenol. Acta Otorrinolaringol Esp 51 (2000) 553-556
2. Bird P.A., Begg E.J., and Zhang M. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28 (2007) 1124-1130
3. Parnes L.S., Sun A.H., and Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109 (1999) 1-17
4. Hamid M., and Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 16 (2008) 434-440
5. Plaza G., and Herráiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 137 (2007) 74-78
6. Morales-Luckie E., Cornejo-Suarez A., and Zaragoza-Contreras M.A. Oral administration of prednisone to control refractory vertigo in Ménière's disease: a pilot study. Otol Neurotol 26 (2005) 1022-1026
7. Garduño-Anaya M.A., Couthino De Toledo H., Hinojosa-González R., et al. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 133 (2005) 285-294
8. Boleas-Aguirre M.S., Lin F.R., and Della Santina C.C. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease. Otol Neurotol 29 (2008) 33-38
9. Herraiz [en prensa]
10. Sendowski I., Abaamrane L., Raffin F., et al. Therapeutic efficacy of intra-cochlear administration of methylprednisolone after acoustic trauma caused by gunshot noise in guinea pigs. Hear Res 22 (2006) 119-127
11. Zhou Y., Zheng H., Shen X., et al. Intratympanic administration of methylprednisolone reduces impact of experimental intensive impulse noise trauma on hearing. Acta Otolaryngol 24 (2008) 1-6
12. Stokroos R., and Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 124 (2004) 172-175
13. Martin E., and Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease. Otol Neurotol 24 (2003) 800-806
14. Harner S.G., Driscoll C.L., Facer G.W., et al. Long-term follow-up of transtympanic gentamicin flor Ménière's syndrome. Otol Neurotol 22 (2001) 210-214
15. Chia S.H., Gamst A.C., and Anderson J.P. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 25 (2004) 544-552
16. Salt A.N., Gill R.M., and Plontke S.K. Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope 118 (2008) 1793-1800
17. Ito J., Endo T., Nakagawa T., et al. A new method for drug application to the inner ear. ORL J Otorhinolaryngol Relat Spec 67 (2005) 272-275
18. Lee K.Y., Nakagawa T., Okano T., et al. Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol Neurotol 28 (2007) 976-981
19. Iwai K., Nakagawa T., Endo T., et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 116 (2006) 529-533
20. Wang J., Pignol B., Chabrier P.E., et al. A novel dual inhibitor of calpains and lipid peroxidation (BN82270) rescues the cochlea from sound trauma. Neuropharmacology 52 (2007) 1426-1437
21. Suckfuell M., Canis M., Strieth S., et al. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol 127 (2007) 938-942
22. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22 (2001) 18-23
23. Gianoli G.J., and Li J.C. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125 (2001) 142-146
24. Ho H.G., Lin H.C., Shu M.T., et al. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114 (2004) 1184-1189
25. Banerjee A., and Parnes L.S. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 26 (2005) 878-881
26. Battista R.A. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132 (2005) 902-905
27. Gouveris H., Selivanova O., and Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 262 (2005) 131-134
28. Herr B.D., and Marzo S.J. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132 (2005) 527-531
29. Lautermann J., Sudhoff H., and Junker R. Transtympanic corticoid therapy for acute profound hearing loss. Eur Arch Otorhinolaryngol 262 (2005) 587-591
30. Slattery W.H., Fisher L.M., Iqbal Z., et al. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 133 (2005) 251-259
31. Haynes D.S., O'Malley M., Cohen S., et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117 (2007) 3-15
32. Xenellis J., Papadimitriou N., Nikolopoulos T., et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134 (2006) 940-945
33. Fitzgerald D.C., and McGuire J.F. Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 116 (2007) 253-256
34. Van Wijck F., Staecker H., and Lefebvre P.P. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 127 (2007) 1012-1017
35. Battaglia A., Burchette R., and Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 30 (2009) 254-255
36. Itoh A., and Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl 481 (1991) 617-623
37. Shea Jr. J., and Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngol Clin North Am 29 (1996) 353-358
38. Silverstein H., Isaacson J.E., Olds M.J., et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 19 (1998) 196-201
39. Sennaroglu L., Dini F.M., Sennaroglu G., et al. Transtympanic dexamethasone application in Ménière's disease: an alternative treatment for intractable vertigo. J Laryngol Otol 113 (1999) 217-221
40. Hirvonen T.P., Peltomaa M., and Ylikoski J. Intratympanic and systemic dexamethasone for Ménière's disease. ORL J Otorhinolaryngol Relat Spec 62 (2000) 117-120
41. Hillman T.M., Arriaga M.A., and Chen D.A. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?. Laryngoscope 113 (2003) 1903-1907
42. Dodson K.M., Woodson E., and Sismanis A. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study. Ear Nose Throat J 83 (2004) 394-398
43. Boleas-Aguirre M.S., Lin F.R., Della Santina C.C., et al. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease. Otol Neurotol 29 (2008) 33-38
44. Rauch S.D., and Oas J.G. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 107 (1997) 49-55
45. Hirsch B.E., and Kamerer D.B. Intratympanic gentamicin therapy for Ménière's disease. Am J Otol 18 (1997) 44-51
46. McFeely W.J., Singleton G.T., Rodriguez F.J., et al. Intratympanic gentamicin treatment for Meniere's disease. Otolaryngol Head Neck Surg 118 (1998) 589-596
47. Kaasinen S., Pyykkö I., Ishizaki H., et al. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol 118 (1998) 294-298
48. Kaplan D.M., Nedzelski J.M., Chen J.M., et al. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 110 (2000) 1298-1305
49. Longridge N.S., and Mallinson A.I. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease. J Otolaryngol 29 (2000) 35-39
50. Quaranta A., Scaringi A., Aloidi A., et al. Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 121 (2001) 387-392
51. Abou-Halawa A.S., and Poe D.S. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease. Otol Neurotol 23 (2002) 494-502
52. Perez N., Martín E., and García-Tapia R. Intratympanic gentamicin for intractable Meniere's disease. Laryngoscope 113 (2003) 456-464
53. Wu I.C., and Minor L.B. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 113 (2003) 815-820